Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan.

Po-Lin LinYing-Hsiang LeeLawrence Yu-Min LiuCheng-Ting TsaiTen-Fang YangWei-Ru ChiouMu-Yang HsiehHung-Yu ChangChun-Che Huang

Published in: Journal of cardiovascular pharmacology and therapeutics (2022)

Prolonged QRS durations and unfavorable LVEF recoveries after sacubitril/valsartan therapy were observed in patients with HFrEF duration of ≥1 year. Earlier diagnosis of HFrEF and appropriate medication treatment may be beneficial in the improvement of QRS duration and LVEF recovery.

Keyphrases

heart failure
cardiac resynchronization therapy
left ventricular
ejection fraction
healthcare
atrial fibrillation
type diabetes
stem cells
left atrial
metabolic syndrome
insulin resistance
cell therapy
weight loss
acute heart failure
glycemic control